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Abstract
Background & Aims: Diet contributes to colorectal cancer development and may be potentially modified. We
wanted to identify the biological mechanisms underlying colorectal carcinogenesis by assessment of diet-gene
interactions.
Methods: The polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C
(rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and
T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish,
fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was
assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected
participants from a prospective study of 57,053 persons.
Results: IL1b C-3737T, G-1464C and PTGS2 T8473C variant genotypes were associated with risk of CRC
compared to the homozygous wildtype genotype (IRR=0.81, 95%CI: 0.68-0.97, p=0.02, and IRR=1.22, 95%CI:
1.04-1.44, p=0.02, IRR=0.75, 95%CI: 0.57-0.99, p=0.04, respectively). Interactions were found between diet and
IL10 rs3024505 (P-value for interaction (Pint); meat=0.04, fish=0.007, fibre=0.0008, vegetables=0.0005), C-592A (Pint;
fibre=0.025), IL1b C-3737T (Pint; vegetables=0.030, NSAID use=0.040) and PTGS2 genotypes G-765C (Pint;
meat=0.006, fibre=0.0003, fruit 0.004), and T8473C (Pint; meat 0.049, fruit=0.03) and A-1195G (Pint; meat 0.038, fibre
0.040, fruit=0.059, vegetables=0.025, and current smoking=0.046).
Conclusions: Genetically determined low COX-2 and high IL-1β activity were associated with increased risk of CRC
in this northern Caucasian cohort. Furthermore, interactions were found between IL10, IL1b, and PTGS2 and diet
and lifestyle factors in relation to CRC. The present study demonstrates that gene-environment interactions may
identify genes and environmental factors involved in colorectal carcinogenesis.
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Introduction
Colorectal cancer (CRC) is one of the most common cancers
in the Western World [1]. Increasing incidence suggests that
lifestyle factors are deeply involved in the etiology of CRC and,
that modification of these factors may affect risk [2]. The
assessment of gene-environment interactions provides a tool
for understanding the underlying biological pathways by which
diet affects colorectal carcinogenesis [3–5]. This topic has
recently been reviewed [6].
Chronic intestinal inflammation is a well-known risk factor for
CRC [7]. Diet and lifestyle factors may affect intestinal
inflammation in many ways, directly or indirectly. Meat, for
example, has been found to affect the intestinal homeostasis
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e.g. by activation of pattern recognition receptors such as toll-
like receptors (TLRs) [8]. Also, meat is a source of n-6 poly-
unsaturated fatty acids (PUFA) which may undergo metabolic
conversion to arachidonic acid and predominantly pro-
inflammatory prostaglandins [9]. Fish is a source of n-3 PUFA,
which may modify inflammation [10]. Furthermore, dietary fibre
from vegetables, fruit and cereals are converted by colonic
bacteria to short-chain fatty acids (SCFA) which have been
found to affect intestinal inflammation in various ways including
stimulation of IL-10 production [11].
IL-10, IL-1β and COX-2 (encoded by IL10, IL1B, and PTGS2,
respectively), are important mediators of intestinal
inflammation. Both SCFA and TLR activation have been found
to affect production of IL-10 and IL-1β and thereby COX-2
activation [11,12]. IL-10 is a key anti-inflammatory cytokine
orchestrating the innate and adaptive immune response. IL-10
-/- mice develop colitis and subsequently colorectal
adenocarcinomas [13]. IL-1β is a proinflammatory cytokine and
genetic variation in IL1B has been associated with risk of lung
cancer and multiple myeloma [14,15]. A central function of
COX-2 in colorectal carcinogenesis is suggested by the finding
that long term use of COX-2 inhibitors (COXIB) has been found
to confer protection against CRC in some studies [16].
The use of functional polymorphisms has the advantage that
the results may allow interpretation of the involved biological
pathways in colorectal carcinogenesis.
We have previously assessed diet and IL10 gene
interactions in a prospective Danish cohort of three hundred
and seventy-eight CRC cases and a comparison group of 775
participants [17]. We found no association with CRC per see,
yet, we found interactions between IL10 polymorphisms and
intake of dietary fibre [17]. We have also previously assessed
genetic variation in IL1B and PTGS2 in this cohort, finding no
statistically significant associations with risk of CRC [3,18]. We
now extend our studies to a larger cohort with more than twice
the number of cases and members of the comparison group
and include more dietary factors and all the three functional
promoter polymorphisms in IL1B.
Therefore, we assessed the functional polymorphisms IL10
C-592A (rs1800872), IL1B C-3737T (rs4848306), G-1464C
(rs1143623), T-31C (rs1143627) and PTGS2 (encoding
COX-2) A-1195G (rs689466), G-765C (rs20417), T8473C
(rs5275) and the IL10 marker polymorphism C-rs3024505-T in
relation to diet (red meat, fish, fibre, cereals, fruit and
vegetables) and lifestyle (non-steroid-anti-inflammatory drug
use and smoking status) in a nested case-cohort study of nine
hundred and seventy CRC cases and 1789 randomly selected
participants from the prospective Diet, Cancer and Health study
encompassing 57,053 persons.
Methods
Studied Subjects
The Diet, Cancer and Health Study is an ongoing Danish
cohort study designed to investigate the relation between diet,
lifestyle and cancer risk [19]. The cohort consists of 57,053
persons, recruited between December 1993 and May 1997. All
the subjects were born in Denmark, and the individuals were
50 to 64 years of age and had no previous cancers at study
entry. Blood samples and questionnaire data on diet and
lifestyle were collected at study entry.
Follow-up and endpoints
Follow-up was based on population-based cancer registries.
Between 1994 and 31th December 2009, nine hundred and
seventy CRC cases were diagnosed. A subcohort of 1897
persons was randomly selected within the cohort. Of these,
108 with missing genotype data were excluded. All information
on genotypes and diet and lifestyle factors was available for
nine hundred and seventy CRC cases and 1789 subcohort
members.
Dietary and lifestyle questionnaire
Information on diet, lifestyle, weight, height, medical
treatment, environmental exposures, and other socio-economic
factors were collected at enrolment using questionnaires and
interviews. In the food-frequency questionnaire, diet
consumption was assessed in 12 categories of predefined
responses, ranking from ’never’ to ’eight times or more per
day’. The daily intake was then calculated by using FoodCalc
[19]; this program uses population specific standardized
recipes and portion sizes. Intake of red meat in grams per day
was calculated by adding up intake of beef, veal, pork, lamb
and offal. Intake of processed meat in grams per day was
calculated by adding up intake of processed red meat,
including bacon, smoked ham, salami, frankfurter, Cumberland
sausage, cold cuts and liver pâté. Dietary fibre intake was
based on country-specific food composition tables, which were
reviewed to ensure comparability to the association of official
analytical chemists (AOAC) fibre definition, which includes
lignin and resistant starch [20]. Fibre intake is calculated by
multiplying the frequency of consumption of relevant foods by
their fibre content as determined from national databases of
food content [21].
Contributing food items to the food group ‘cereals’ included
wholegrain foods (wholegrain bread, rye bread, wholegrain
flour, oatmeal, corncobs, müsli, and crispbread) and refined
grain foods (white wheat bread, wheat flour, rice flour, potato
flour, corn flour/starch, pasta, wheat) and was measured in
grams per day [22]. Intake of ‘fish’ in grams per day was
calculated by adding up intake of fresh and processed fish. For
fruit, only intake of fresh fruit (as indicated on the FFQ) was
examined, while vegetable intake also included estimated
contributions from recipes. The questionnaire was tested in a
validation study preceding the Diet, Cancer and Health study.
Pearson correlation coefficients (adjusted for total energy
intake) illustrating the comparison of nutrient scores estimated
from the food-frequency questionnaire and from weighed diet
records were 0.39 and 0.53 for dietary fibre and 0.37 and 0.14
for meat for men and women, respectively [23,24].
Smoking status was classified as never, past or current.
Persons smoking at least 1 cigarette daily during the last year
were classified as smokers.
The lifestyle questionnaire included this question regarding
use of NSAID: “Have you taken more than one pain relieving
pill per month during the last year?” If the answer was yes, the
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participant was asked to record how frequently they took each
of the following medications: “Aspirin”, “Paracetamol”,
“Ibuprofen”, or “Other pain relievers”. The latter category
included NSAID preparations other than aspirin and ibuprofen.
Based on all records, we classified study subjects according to
use of “any NSAID” (≥ 2 pills per month during one year) at
baseline.
Genotyping
Buffy coat preparations were stored at minus 150°C until
use. DNA was extracted as described [25]. The DNA was
genotyped by KBioscience (KBioscience, Hoddesdon, United
Kingdom) by PCR-based KASP™ genotyping assay. (http://
www.lgcgenomics.com/). One marker polymorphism, the IL10
C-rs3024505-T, and 8 functional polymorphisms were selected;
IL10 C-592A (rs1800872), IL1B C-3737T (rs4848306),
G-1464C (rs1143623), T-31C (rs1143627) and PTGS2
(encoding COX-2) A-1195G (rs689466), G-765C (rs20417),
and T8473C (rs5275). IL1B T-31C (rs1143627) [18], PTGS2
(encoding COX-2) A-1195G (rs689466), G-765C (rs20417),
and T8473C (rs5275) [3] were determined and reported
previously for a subset of the study group. Furthermore, all the
three SNPs in IL1B were determined for the whole comparison
group independently of the present work and reported
previously [26]. To confirm reproducibility, genotyping was
repeated for 10 % of the samples yielding 100% identity.
Statistical Analysis
Deviation from Hardy-Weinberg equilibrium was assessed
using a Chi square test.
Incidence rate ratios (IRR) and 95% Confidence Interval
(95%CI) were calculated according to the principles for
analysis of case-cohort studies using an un-weighted approach
[27]. Age was used as the time scale in the Cox regression
models. Tests and confidence intervals were based on Wald’s
tests using the robust estimate of the variance-covariance
matrix for the regression parameters in the Cox regression
models [28] as previously described [3,5,17,18,29–34].
All models were adjusted for baseline values of suspected
risk factors for colorectal cancer such as body mass index
(BMI) (kg/m2, continuous), NSAID (yes/no), use of hormone
replacement therapy (HRT) (never/past/current, among
women), smoking status (never/past/current), intake of dietary
fibre (g/day, continuous), and red meat and processed meat (g/
day, continuous). Cereals, fibre, fruit and vegetables were also
entered linearly. All analyses were stratified by gender, so that
the basic (underlying) hazards were gender specific. For all the
polymorphisms, IRR was calculated separately for
heterozygous and homozygous variant allele carriers. For all
the SNPs except for PTGS2 A-1195G, all variant allele carriers
were subsequently grouped for interaction analyses since no
recessive effects were observed. For PTGS2 A-1195G, a
recessive mode was used in the subsequent analyses.
Haplotypes of PTGS2 and IL1B were inferred manually as
done previously [3,35,36].
For the different genes, we investigated possible interactions
between the polymorphisms and intake of meat, dietary fibre,
cereals, fish, fruit and vegetables, smoking status and NSAID
use using the likelihood ratio test [3,14,32,35–37].
In another set of interaction analyses between the
polymorphisms and the dietary intake subdivided in tertiles,
dietary intake was entered as a categorical variable. Tertile cut-
points were based on the empirical distribution among cases.
The possible interactions were investigated using the likelihood
ratio test.
All analyses were performed using R version 2.15-1 (R Core
Team, 2013) [38]. A p<0.05 was considered to be significant.
Ethics Statement
All participants gave verbal and written informed consent.
The Diet, Cancer and Health study was approved by the
National Committee on Health Research Ethics (journal nr.
(KF) 01-345/93) and the Danish Data Protection Agency.
Results
Characteristics of the study population and risk factors for
CRC are shown in Table 1. The genotype distribution of the
polymorphisms in the sub-cohort did not deviate from Hardy-
Weinberg equilibrium (results not shown). The variant allele
frequency in the sub-cohort were for IL10 C-592A 0.22,
rs3024505 0.17, IL1B C-3737T 0.43, G-1464C 0.27, T-31C
0.33 and PTGS2 A-1195G 0.19, G-765C 0.15, and T8473C
0.34, respectively.
Associations between polymorphisms and CRC
IL1B C-3737T variant allele carriers were at lowered risk of
CRC and the G-1464C variant allele carriers were at higher risk
of CRC compared to the homozygous wildtype genotype
carriers (p=0.02 and p=0.02, respectively) (Table 2). Haplotype
analyses revealed that the IL1B haplotype combinations which
included the CCC haplotype (C-3737T, G-1464C, T-31C) were
associated with increased risk of CRC compared to the
reference TGT/TGT haplotype (Table S1). However, only the
haplotype combination CCC/CGT were statistically significantly
associated with risk of CRC (p=0.02). Carriers of one copy of
the haplotype CCC had an IRR of 1.20 (p=0.04) and carriers of
two CCC haplotypes had an IRR of 1.29 (p=0.12) (reference
group: no CCC haplotype) (Table 3). Carriers of one copy of
the TGT haplotype had an IRR of 0.82 (p=0.04) and carriers of
two TGT copies had an IRR of 0.79 (p=0.05) (Table 3).
Carriers of the high COX-2 activity PTGS2 T8473C variant
allele were at lower risk of CRC and homozygous carriers of
the low COX-2 activity PTGS2 A-1195G variant G-allele were
at marginally higher risk of CRC than the homozygous wildtype
genotype (p=0.02 and p=0.07, respectively) (Table 2).
Furthermore, carriers of the haplotype combination which
included both copies of the A-1195G variant alleles (GGT/
GGT), were at increased risk of CRC (p=0.09) compared to the
reference PTGS2 AGT/AGT (A-1195G, G-765C, T8473C)
haplotype combination (Table S1). In a separate analysis,
carriers of one GGT copy had an IRR of 1.06 (p=0.51) whereas
carriers of two copies had an IRR of 1.62 compared to all non-
carriers of the haplotype (p=0.02) (Table 3).
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Where no recessive effects were observed, variant
genotypes were combined in the interaction analysis to
maximize the statistical power. A recessive effect was found for
PTGS2 A-1195G and consequently, AA and AG carriers were
grouped versus GG carriers.
Gene-environment analyses
Meat.  IL10 rs3024505 variant carriers were at 6% increased
risk of CRC per 25 g red and processed meat per day (95%CI:
1.00-1.11) whereas homozygous wildtype carriers were at no
risk by meat intake (P-value for interaction (Pint)=0.04) (Table
Table 1. Baseline characteristics of study population
selected for the Diet, Cancer and Health cohort.
 Cases  Sub-cohort
Test for
difference
 No. Medians  No. Medians p-value
 (%) (5-95%percentiles)  (%)
(5-95%
percentiles)  
Total 970(100)   1789(100)   
Sex      0.13
Men 547(56)   954 (53)   
Women 423(44)   835 (47)   
Age at
inclusion
(years)
 58 (51-64)   56 (50-64) <1e-16
BMI
( kg/m2)  
26.3
(20.7-34.3)   
25.6
(20.5-33.0) 0.001
Food intake
(g/day)       
Alcohol1  14.0(0.5-69.9)   
13.5
(0.7-65.4) 0.23
Dietary fiber  20.0(10.6-32.8)   
20.6
(10.8-34.2) 0.01
Red and
processed
meat
 113 (47-233)   109 (42-236) 0.03
Smoking
status      0.07
Never 286 (30)   603 (34)   
Past 301 (31)   518 (29)   
Current 383 (40)   667 (37)   
NSAID use      0.65
No 699 (70)   1218 (69)   
Yes 293 (30)   557 (31)   
HRT use
among
women2
     0.01
Never 258 (61)   437 (52)   
Past 55 (13)   132 (16)   
Current 110 (26)   266 (32)   
1 Among current drinkers
2 Percentages among female cases/members of the comparison group
doi: 10.1371/journal.pone.0078366.t001
Table 2. Incidence rate ratios and 95% confidence intervals
for the studied gene polymorphisms in the Diet, Cancer and
Health study.
  Ncase
Nsub-
cohort Crude
a Adjustedb P-valuec
   IRR (95%CI) IRR (95%CI)  
IL10 C-592A          
 CC 596 1072 1.00   1.00    
 AC 297 580 0.92 (0.78-1.10) 0.92 (0.77-1.10) 0.38
 AA 56 96 1.02 (0.71-1.45) 1.00 (0.70-1.44) 0.98
 AC-AA 353 676 0.94 (0.79-1.11) 0.93 (0.79-1.11) 0.44
IL10 rs3024505          
 CC 648 1200 1.00   1.00    
 CT 263 511 0.97 (0.81-1.16) 0.98 (0.82-1.18) 0.87
 TT 34 54 1.03 (0.66-1.63) 0.99 (0.62-1.58) 0.96
 CT-TT 297 565 0.98 (0.82-1.16) 0.98 (0.83-1.17) 0.87
IL1B C-3737T          
 CC 336 560 1.00   1.00    
 CT 433 835 0.84 (0.70-1.01) 0.82 (0.68-0.99) 0.04
 TT 172 351 0.79 (0.63-1.00) 0.79 (0.63-1.01) 0.06
 CT-TT 605 1186 0.83 (0.70-0.98) 0.81 (0.68-0.97) 0.02
IL1B G-1464C          
 GG 454 925 1.00   1.00    
 CG 408 683 1.21 (1.02-1.43) 1.21 (1.02-1.44) 0.03
 CC 84 141 1.26 (0.93-1.71) 1.30 (0.95-1.77) 0.10
 CG-CC 492 824 1.21 (1.03-1.43) 1.22 (1.04-1.44) 0.02
IL1B T-31C          
 TT 389 773 1.00   1.00    
 TC 440 779 1.10 (0.93-1.31) 1.11 (0.93-1.32) 0.26
 CC 117 204 1.22 (0.94-1.59) 1.22 (0.93-1.59) 0.16
 TC-CC 557 983 1.13 (0.96-1.33) 1.13 (0.95-1.33) 0.16
PTGS2
A-1195G          
 AA 587 1126 1.00   1.00    
 AG 313 560 1.06 (0.89-1.27) 1.07 (0.90-1.28) 0.43
 GG 47 61 1.41 (0.94-2.11) 1.46 (0.97-2.20) 0.07
 AA-AG vsGGd 900 1686 1.38 (0.93-2.05) 1.42 (0.95-2.14) 0.09
PTGS2 G-765C          
 GG 701 1256 1.00   1.00    
 GC 213 435 0.90 (0.74-1.09) 0.86 (0.71-1.05) 0.14
 CC 22 43 0.91 (0.54-1.54) 0.96 (0.56-1.63) 0.88
 GC-CC 235 478 0.90 (0.75-1.08) 0.87 (0.72-1.05) 0.15
PTGS2 T8473C          
 TT 430 720 1.00   1.00    
 CT 404 815 0.86 (0.72-1.02) 0.84 (0.71-1.01) 0.06
 CC 97 203 0.77 (0.59-1.02) 0.75 (0.57-0.99) 0.04
 CT-CC 501 1018 0.84 (0.71-0.99) 0.82 (0.70-0.97) 0.02
a Adjusted for sex and age
b In addition, adjusted for smoking status, alcohol, HRT status (women only), BMI,
use of NSAID, and intake of red and processed meat, and dietary fibre
c P-value for the adjusted estimates
d AA and AG versus GG.
doi: 10.1371/journal.pone.0078366.t002
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4). These findings were supported by the tertile analyses
(Table S2). IL10 rs3024505 variant carriers were at 1.50
increased risk by high meat intake compared to homozygous
wildtype carriers with low meat intake (95%CI: 1.09-2.06,
Pint=0.02).
PTGS2 G-765C variant allele carriers were at 8% increased
risk of CRC per 25 g red and processed meat per day (95% CI:
1.00-1.15) whereas homozygous wildtype carriers were at no
risk by meat intake (Pint=0.006) (Table 4). Also, PTGS2 G-765C
variant allele carriers were at increased risk of CRC by meat
intake in the tertile analysis compared to the homozygous
wildtype carriers (Pint=0.005) (Table S2).
Fish.  IL10 rs3024505 homozygous wildtype carriers were at
10 % reduced risk of CRC per 25 g fish per day whereas
variant carriers had no risk reduction by similar intake
(Pint=0.007).
Fibre, fruit, vegetables, and cereals.  IL10 rs3024505
homozygous wildtype carriers were at 23 and 6 % reduced risk
of CRC per 10 g fibre and 50 g vegetables per day whereas
variant carriers had no risk reduction by similar intake
(Pint=0.0008, and 0.0005, respectively). Furthermore, IL10
rs3024505 homozygous wildtype carriers were at lowered risk
of CRC among study participants with the highest intake of
fibre (IRR=0.73, 95%CI: 0.57-0.94, Pint=0.007) and vegetables
(IRR=0.72, 95%CI: 0.56-0.93, Pint=0.001).
PTGS2 G-765C homozygous wildtype carriers were at 21%
and 5% reduced risk of CRC per 10 g fibre and 50 g fruit per
day whereas variant carriers had no risk reduction by similar
intake (Pint=0.0003, and 0.004, respectively). In the tertile
analysis, PTGS2 G-765C homozygous wildtype carriers were
at low risk of CRC by high intake of fibre (IRR=0.71, 95% CI:
0.55-0.90, Pint=0.004), and fruit (IRR=0.73, 95% CI: 0.57-0.93,
Pint=0.006).No interaction between any genotypes and cereal in
relation to risk of CRC was found (Table 4). In the tertile
analyses, IL1B G-3737C variant allele carriers were at lowered
risk of CRC in the lowest tertile of vegetables (IRR=0.66, 95%
CI: 0.49-0.89) whereas the risk estimates in the highest tertile
was similar for the two alleles (Pint=0.03) (Table S2).
NSAID use.  A statistically significant association between
IL1B C-3737T and use of NSAID was found (Table S3). Low
risk of CRC was found for the IL1B C-3737T variant allele
carriers among non-NSAID users (IRR=0.74, 95% CI:
0.60-0.91) but not among NSAID users (IRR=0.82, 95% CI:
0.64-1.06) compared to the homozygous wildtype carriers
(reference) (Pint=0.04).
Smoking.  A statistically significant association between
PTGS2 A-1195G and smoking was found (Table S4). Among
current smokers, homozygous PTGS2 A-1195G variant allele
carriers were at higher risk of CRC (IRR=2.33, 95% CI:
1.13-4.78, Pint=0.046) compared to homozygous wildtype
carriers who had never smoked (reference group).
Discussion
In the present candidate gene study, we analysed gene-
environment interactions in relation to risk of CRC in a Danish
prospective cohort. We found that functional IL1B and PTGS2
polymorphisms were associated with risk of CRC (Table 2 and
3, and Table S1). Furthermore, we found interactions between
diet and lifestyle factors and genes involved in the inflammatory
pathway (Table 3 and Table S2, S3 and S4). Thus, we found
interactions between intake of meat and IL10 and PTGS2, fish
and IL10, fibre and IL10 and PTGS2, fruit and PTGS2,
vegetables and IL10, PTGS2, and IL1B, NSAID use and IL1B,
and, finally, between smoking status and PTGS2
polymorphisms.
Associations between polymorphisms and CRC
We now extend our previous studies of IL10, IL1B and
PTGS2 polymorphisms in relation to diet and colorectal
carcinogenesis in a study group of three hundred and seventy-
Table 3. Risk estimates for IL1B and PTGS2 haplotypes in relation to risk of colorectal cancer.
  Copy Ncases Nsubcohort IRRa (95%CI)  IRRb (95%CI)  P-valuec
IL1B TGT 0 330 563 1   1    
  1 424 840 0.84 (0.70-1.01) 0.82 (0.68-0.99) 0.035
  2 168 353 0.78 (0.62-0.99) 0.79 (0.62-1.00) 0.051
 CCC 0 444 929 1   1    
  1 397 688 1.20 1.02-1.43) 1.20 (1.01-1.43) 0.040
  2 81 139 1.25 (0.92-1.70) 1.29 (0.94-1.76) 0.116
PTGS2 GGT 0 560 1104 1   1    
  1 296 559 1.05 (0.88-1.25) 1.06 (0.89-1.27) 0.514
  2 46 57 1.58 (1.04-2.38) 1.62 (1.06-2.47) 0.024
 AGT 0 144 267 1   1    
  1 573 1110 1.01 (0.80-1.27) 1.01 (0.80-1.27) 0.952
  2 185 343 1.05 (0.80-1.39) 1.05 (0.79-1.39) 0.750
Haplotype sequence: IL1B: C-3737T, G-1464C, T-31C. PTGS2: A-1195G, G-765C, T8473C
a Adjusted for sex and age
b In addition, adjusted for smoking status, alcohol, HRT status (women only), BMI, intake of red and processed meat, and dietary fibre
c P-value for the adjusted risk estimates
doi: 10.1371/journal.pone.0078366.t003
IL-10, IL-1β, COX-2, Diet and Colorectal Cancer
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e78366
Ta
ble
 4.
 In
ter
ac
tio
n b
etw
ee
n d
iet
ary
 fa
cto
rs 
an
d t
he
 st
ud
ied
 po
lym
orp
his
ms
 in
 re
lat
ion
 to
 co
lor
ec
tal
 ca
nc
er 
ris
k.
 
 
 
IR
Ra
(95
%C
I)
IR
Rb
(95
%C
I)
P-
va
lue
 
IR
Ra
(95
%C
I)
IR
Rb
(95
%C
I)
P-
va
lue
 
IR
Ra
(95
%C
I)
IR
Rb
(95
%C
I)
P-
va
lue
c
 
 
 
Re
d a
nd
 pr
oc
es
se
d m
ea
t p
er
 25
 g/
da
y
 
Fis
h p
er
 25
 g/
da
y
 
Di
eta
ry
 ce
re
al 
pe
r 5
0 g
/da
y
 
IL1
0
C-
59
2A
CC
1.0
3
(0.
99
-1.
07
)
1.0
2
(0.
98
-1.
06
)
 
0.9
4
(0.
85
-1.
04
)
0.9
4
(0.
85
-1.
04
)
 
0.9
5
(0.
89
-1.
02
)
0.9
7
(0.
90
-1.
04
)
 
 
AC
-A
A
1.0
1
(0.
96
-1.
07
)
1.0
0
(0.
95
-1.
06
)
0.4
55
3
 
0.9
9
(0.
88
-1.
12
)
0.9
8
(0.
86
-1.
11
)
0.5
59
6
 
0.9
3
(0.
85
-1.
02
)
0.9
5
(0.
86
-1.
04
)
0.6
41
9
 
rs3
02
45
05
CC
1.0
1
(0.
97
-1.
05
)
1.0
0
(0.
96
-1.
04
)
 
0.9
1
(0.
83
-1.
00
)
0.9
0
(0.
82
-0.
99
)
 
0.9
3
(0.
86
-0.
99
)
0.9
4
(0.
87
-1.
02
)
 
 
CT
-T
T
1.0
6
(1.
01
-1.
11
)
1.0
6
(1.
00
-1.
11
)
0.0
36
1
 
1.0
8
(0.
94
-1.
24
)
1.0
8
(0.
94
-1.
24
)
0.0
06
5
 
0.9
8
(0.
90
-1.
07
)
0.9
9
(0.
90
-1.
09
)
0.2
71
5
IL1
B
C-
37
37
T
CC
1.0
1
(0.
96
-1.
07
)
1.0
1
(0.
96
-1.
07
)
 
0.9
8
(0.
86
-1.
11
)
0.9
8
(0.
86
-1.
11
)
 
0.9
8
(0.
89
-1.
08
)
1.0
0
(0.
90
-1.
11
)
 
 
CT
-T
T
1.0
3
(0.
99
-1.
07
)
1.0
2
(0.
98
-1.
06
)
0.6
51
9
 
0.9
4
(0.
86
-1.
04
)
0.9
3
(0.
84
-1.
03
)
0.4
59
0
 
0.9
2
(0.
86
-0.
99
)
0.9
4
(0.
87
-1.
01
)
0.1
74
3
 
G-
14
64
C
GG
1.0
2
(0.
98
-1.
07
)
1.0
2
(0.
97
-1.
06
)
 
0.9
5
(0.
86
-1.
05
)
0.9
4
(0.
85
-1.
04
)
 
0.9
3
(0.
86
-1.
01
)
0.9
5
(0.
88
-1.
03
)
 
 
GC
-C
C
1.0
3
(0.
98
-1.
08
)
1.0
2
(0.
97
-1.
07
)
0.9
36
7
 
0.9
7
(0.
86
-1.
08
)
0.9
7
(0.
86
-1.
09
)
0.6
22
7
 
0.9
5
(0.
88
-1.
03
)
0.9
6
(0.
88
-1.
05
)
0.7
63
0
 
T-
31
C
TT
1.0
1
(0.
96
-1.
05
)
1.0
0
(0.
96
-1.
05
)
 
0.9
3
(0.
83
-1.
03
)
0.9
1
(0.
81
-1.
03
)
 
0.9
2
(0.
85
-1.
00
)
0.9
5
(0.
87
-1.
03
)
 
 
TC
-C
C
1.0
4
(0.
99
-1.
08
)
1.0
3
(0.
98
-1.
07
)
0.3
95
4
 
0.9
8
(0.
88
-1.
08
)
0.9
8
(0.
88
-1.
09
)
0.3
08
9
 
0.9
5
(0.
88
-1.
03
)
0.9
6
(0.
89
-1.
04
)
0.7
25
2
PT
GS
2
A-
11
95
G
AA
-A
G
1.0
2
(0.
99
-1.
06
)
1.0
2
(0.
98
-1.
05
)
 
0.9
6
(0.
89
-1.
04
)
0.9
6
(0.
84
81
.04
)
 
0.9
5
(0.
90
-1.
01
)
0.9
7
(0.
91
-1.
03
)
 
 
GG
1.0
5
(0.
87
-1.
27
)
1.0
6
(0.
87
-1.
29
)
0.5
43
9
 
0.8
2
(0.
54
-1.
23
)
0.7
8
(0.
51
-1.
19
)
0.2
11
6
 
0.7
7
(0.
58
-1.
03
)
0.7
7
(0.
58
-1.
04
)
0.0
38
7
 
G-
76
5C
GG
1.0
0
(0.
96
-1.
04
)
0.9
9
(0.
95
-1.
03
)
 
0.9
3
(0.
85
-1.
01
)
0.9
2
(0.
84
-1.
01
)
 
0.9
3
(0.
87
-0.
99
)
0.9
4
(0.
88
-1.
01
)
 
 
GC
-C
C
1.0
8
(1.
01
-1.
15
)
1.0
8
(1.
01
-1.
15
)
0.0
05
8
 
1.0
5
(0.
90
-1.
23
)
1.0
5
(0.
89
-1.
25
)
0.0
66
3
 
0.9
9
(0.
89
-1.
10
)
1.0
1
(0.
91
-1.
12
)
0.1
77
1
 
T8
47
3C
TT
1.0
4
(0.
99
-1.
10
)
1.0
4
(0.
99
-1.
09
)
 
0.9
5
(0.
85
-1.
05
)
0.9
4
(0.
84
-1.
05
)
 
0.9
3
(0.
86
-1.
01
)
0.9
5
(0.
87
-1.
03
)
 
 
TC
-C
C
1.0
1
(0.
97
-1.
06
)
1.0
1
(0.
96
-1.
05
)
0.2
92
4
 
0.9
6
(0.
87
-1.
07
)
0.9
5
(0.
85
-1.
07
)
0.8
02
9
 
0.9
4
(0.
87
-1.
02
)
0.9
6
(0.
88
-1.
04
)
0.8
57
3
 
 
 
Di
eta
ry
 fib
re
 pe
r 1
0 g
/da
y
 
Fr
uit
 pe
r 5
0 g
/da
y
 
Ve
ge
tab
les
 pe
r 5
0 g
/da
y
IL1
0
C-
59
2A
CC
0.8
7
(0.
76
-1.
00
)
0.9
1
(0.
78
-1.
05
)
 
0.9
7
(0.
94
-1.
00
)
0.9
8
(0.
94
-1.
01
)
 
0.9
8
(0.
93
-1.
03
)
0.9
9
(0.
94
-1.
04
)
 
 
AC
-A
A
0.7
9
(0.
64
-0.
96
)
0.7
9
(0.
64
-0.
98
)
0.1
63
8
 
0.9
6
(0.
92
-1.
00
)
0.9
6
(0.
92
-1.
00
)
0.3
44
3
 
0.9
6
(0.
89
-1.
04
)
0.9
7
(0.
89
-1.
04
)
0.5
04
3
 
rs3
02
45
05
CC
0.7
5
(0.
65
-0.
87
)
0.7
7
(0.
66
-0.
89
)
 
0.9
6
(0.
93
-0.
99
)
0.9
6
(0.
93
-0.
99
)
 
0.9
3
(0.
89
-0.
99
)
0.9
4
(0.
89
-0.
99
)
 
 
CT
-T
T
1.0
3
(0.
85
-1.
25
)
1.0
6
(0.
87
-1.
30
)
0.0
00
8
 
0.9
8
(0.
93
-1.
03
)
0.9
9
(0.
94
-1.
04
)
0.1
89
1
 
1.0
4
(0.
98
-1.
11
)
1.0
6
(0.
99
-1.
13
)
0.0
00
5
IL1
B
C-
37
37
T
CC
0.8
1
(0.
66
-0.
99
)
0.8
3
(0.
67
-1.
02
)
 
0.9
6
(0.
93
-1.
00
)
0.9
6
(0.
92
-1.
00
)
 
0.9
4
(0.
87
-1.
01
)
0.9
4
(0.
86
-1.
02
)
 
 
CT
-T
T
0.8
5
(0.
73
-0.
98
)
0.8
8
(0.
75
-1.
02
)
0.5
69
5
 
0.9
6
(0.
93
-1.
00
)
0.9
7
(0.
94
-1.
00
)
0.7
16
6
 
0.9
8
(0.
94
-1.
03
)
1.0
0
(0.
95
-1.
05
)
0.0
70
5
 
G-
14
64
C
GG
0.8
3
(0.
71
-0.
98
)
0.8
7
(0.
74
-1.
03
)
 
0.9
7
(0.
93
-1.
00
)
0.9
7
(0.
94
-1.
01
)
 
0.9
5
(0.
90
-1.
00
)
0.9
6
(0.
91
-1.
02
)
 
 
GC
-C
C
0.8
4
(0.
71
-0.
99
)
0.8
5
(0.
72
-1.
01
)
0.8
18
1
 
0.9
6
(0.
92
-1.
00
)
0.9
6
(0.
92
-1.
00
)
0.5
95
5
 
1.0
0
(0.
93
-1.
06
)
1.0
0
(0.
94
-1.
07
)
0.2
08
2
 
T-
31
C
TT
0.8
2
(0.
69
-0.
97
)
0.8
6
(0.
72
-1.
03
)
 
0.9
7
(0.
93
-1.
01
)
0.9
8
(0.
94
-1.
01
)
 
0.9
6
(0.
91
-1.
02
)
0.9
7
(0.
92
-1.
03
)
 
 
TC
-C
C
0.8
5
(0.
73
-0.
99
)
0.8
6
(0.
73
-1.
01
)
0.9
90
4
 
0.9
6
(0.
92
-0.
99
)
0.9
6
(0.
93
-1.
00
)
0.4
71
5
 
0.9
7
(0.
92
-1.
03
)
0.9
8
(0.
92
-1.
05
)
0.8
11
0
PT
GS
2
A-
11
95
G
AA
-A
G
0.8
5
(0.
76
-0.
96
)
0.8
8
(0.
78
-1.
00
)
 
0.9
6
(0.
94
-0.
99
)
0.9
7
(0.
94
-0.
99
)
 
0.9
7
(0.
93
-1.
01
)
0.9
8
(0.
94
-1.
03
)
 
 
GG
0.4
9
(0.
23
-1.
07
)
0.4
7
(0.
21
-1.
05
)
0.0
22
4
 
0.9
4
(0.
79
-1.
12
)
0.9
4
(0.
77
-1.
12
)
0.6
24
6
 
0.9
2
(0.
77
-1.
11
)
0.9
1
(0.
77
-1.
09
)
0.3
05
3
 
G-
76
5C
GG
0.7
6
(0.
67
-0.
87
)
0.7
9
(0.
68
-0.
91
)
 
0.9
5
(0.
92
-0.
98
)
0.9
5
(0.
92
-0.
98
)
 
0.9
6
(0.
92
-1.
01
)
0.9
8
(0.
93
-1.
03
)
 
 
GC
-C
C
1.1
3
(0.
90
-1.
40
)
1.1
6
(0.
93
-1.
46
)
0.0
00
3
 
1.0
2
(0.
96
-1.
07
)
1.0
2
(0.
97
-1.
07
)
0.0
04
1
 
1.0
1
(0.
93
-1.
10
)
1.0
2
(0.
94
-1.
12
)
0.2
45
7
 
T8
47
3C
TT
0.7
6
(0.
63
-0.
90
)
0.7
9
(0.
65
-0.
94
)
 
0.9
4
(0.
90
-0.
97
)
0.9
4
(0.
91
-0.
98
)
 
0.9
6
(0.
90
-1.
02
)
0.9
7
(0.
91
-1.
03
)
 
 
TC
-C
C
0.9
2
(0.
79
-1.
07
)
0.9
4
(0.
80
-1.
10
)
0.0
68
4
 
0.9
9
(0.
95
-1.
02
)
0.9
9
(0.
96
-1.
02
)
0.0
33
3
 
0.9
9
(0.
93
-1.
05
)
1.0
0
(0.
94
-1.
06
)
0.3
80
0
a  C
rud
e a
dju
ste
d f
or 
se
x a
nd
 ag
e
b  A
dju
ste
d f
or 
sm
ok
ing
 st
atu
s, 
Alc
oh
ol,
 H
RT
 st
atu
s (
wo
me
n o
nly
), B
MI
, in
tak
e o
f re
d a
nd
 pr
oc
es
se
d m
ea
t, a
nd
 di
eta
ry 
fib
re
c  P
 p-
va
lue
 fo
r in
ter
ac
tio
n t
he
 ad
jus
ted
 ris
k e
sti
ma
tes
do
i: 1
0.1
37
1/j
ou
rna
l.p
on
e.0
07
83
66
.t0
04
IL-10, IL-1β, COX-2, Diet and Colorectal Cancer
PLOS ONE | www.plosone.org 6 October 2013 | Volume 8 | Issue 10 | e78366
eight CRC cases and 775 participants in a randomly selected
comparison group [3,17,18] studies to a larger cohort with more
than twice the number of cases and members of the
comparison group and include more dietary factors. In contrast
to our previous findings [3,18], the studied functional
polymorphisms in IL1B and PTGS2 were associated with risk
of CRC in the present larger study group probably reflecting the
increased statistical power. We reproduced the previous
findings that the studied IL10 polymorphisms were not
associated with risk of CRC per see 17.
In the present study, the IL1B CCC (C-3737T, G-1464C,
T-31C) haplotype was associated with increased risk of CRC.
This haplotype gives high transcription levels in studies of the
promoter using transient transfections [39]. Conversely, the
TGT haplotype was associated with low CRC risk. This
haplotype leads to low IL1B transcription and encompasses the
variant allele of C-3737T. The IL1B C-3737T polymorphism
abolishes a binding site for the anti-inflammatory NF-κB subunit
p50 [39]. Thus, our results, both in terms of SNP analyses and
haplotype analyses consistently indicate that genetically
determined high IL1B levels are associated with increased risk
of CRC and genetically low IL1B levels leads to lowered risk of
CRC. Furthermore, our result may suggest involvement of the
anti-inflammatory p50 subunit of NF-κB. We found no
statistically significant interaction between the studied IL1B
polymorphisms and any of the studied diet variables. However,
in the tertile analysis of vegetable intake (table S2) the
association between the IL1B polymorphisms and risk of CRC
was strongest in the lowest tertile. Thus, carriers of the variant
allele of IL1B G-1464C and T-31C were at 1.40 (95%CI:
1.05-1.86) and 1.47 (95%CI: 1.11-1.95) fold increased risk of
CRC, respectively, whereas carriers of the variant allele of
C-3737T were at reduced risk of CRC (IRR=0.66, 95% CI:
0.49-0.89). This may suggest that the association between
IL1B polymorphisms and risk of CRC can only be detected in
populations with relatively low vegetable intake such as the
Danish population [40].
The PTGS2 A-1195G variant allele leads to low transcription
levels of COX-2 [41] whereas PTGS2 T8473C gives high
mRNA levels [42]. In Danes including the present study group,
the variant allele of G-765C almost exclusively co-segregates
with the variant allele of T8473C (Table S1). This haplotype
has been shown to be associated with highly elevated COX-2
activity [43]. In the present study, the PTGS2 GGT (A-1195G,
G-765C, T8473C) haplotype was associated with increased
risk of CRC (P=0.024). The PTGS2 A-1195G homozygous
variant genotype was marginally associated with increased risk
of CRC (P=0.07) and PTGS2 T8473C variant carriers with
genetically determined high COX-2 activity were at lowered risk
of CRC (P=0.02). In accordance with the present study,
genetically low COX-2 activity was found to predispose to
inflammatory bowel disease, a risk factor for CRC [44].
Gene-environment analyses
The intake of meat in the Danish population is among the
highest intakes world-wide and we have previously identified
interactions between meat and genes [3,5]. We found
interaction between intake of meat and PTGS2 G-765C. Thus,
among variant allele carriers, daily intake of meat was
associated with 8% increased risk of CRC pr 25g meat,
whereas homozygous wildtype allele carriers were not at
increased risk (Pint=0.006). The result is in accordance with the
finding of a statistically significant association between PTGS2
G-765C variant genotypes and CRC among subjects with high
n-6 PUFA intake in a prospective, population-based cohort of
310 Singapore Chinese cases [45]. N-6 PUFA is present in
meat. We also found interaction between meat intake and IL10
rs3024505. A similar interaction was found for fish intake.
However, it is difficult to interpret the functional implications as
IL10 rs3024505 is a marker SNP with no known function. The
lack of interaction with the functional promoter polymorphism
C-592A may suggest that the detected interaction may be
related to other genes than IL10, but on the other hand, IL10
rs3024505 is located very far away from other genes [46]. In
summary, the interactions between meat intake on one hand
and genetic variation in PTGS2 and IL10 on the other hand,
suggest that inflammation plays a role in meat related
carcinogenesis. In support of this, we have also found
interaction between the functional promoter polymorphism
NFKB1 -94ins/del and meat intake in relation to CRC [5].
We observed strong interaction between the marker IL10
rs3024505 and intake of fibre and vegetables. In both cases,
homozygous wildtype allele carriers benefited from high intake,
whereas variant allele carriers had no risk reduction when
eating fibre or vegetables in relation to CRC risk. However,
since variant allele carriers in the tertile with the lowest fibre
intake were at marginally lowered risk of CRC (IRR: 0.73, 95%
CI: 0.54-1.01) the results suggest that wildtype allele carriers
experience a risk reduction by fibre intake that variant allele
carriers already have. The results support and extend our
previously finding of interaction between fibre and IL10 in a
subcohort of the present study cohort [17]. Similarly, we
observed interactions between dietary fibre, dietary cereals and
fruit on one hand and genetic variation in PTGS2 on the other.
The interactions are quite consistent and suggest that subjects
with genetically low PTGS2 activity benefit the most from high
intake of fibres, fruit, and cereals. Furthermore, tertile analyses
showed that those with the genetically determined lowest
COX-2 activity, namely homozygous carriers of the variant
allele of PTGS2 A-1195G, were at high risk of CRC in the
group with the lowest intake of fibres (IRR=3.08 (95%CI:
1.51-6.28), and fruits (IRR=2.11, 95%CI: 1.03-4.33), whereas
those with the genetically determined high COX-2 activity,
carriers of the variant allele of PTGS2 G-765C, were at low
CRC risk even in the tertile with the lowest fibre intake
(IRR=0.69, 95% CI: 0.50-0.96). Thus, COX-2 seems intimately
implicated in the biological mechanism underlying the
protective effect of fibres in relation to CRC.
We found interaction between NSAID use and IL1B C-3737T
in relation to development of CRC suggesting that NSAID
intake reduce the risk of CRC among those with high risk of
CRC due to genetically determined high IL1B level. We found
no statistically significant interaction between NSAID and
COX-2 in relation to CRC. A non-statistically significant
tendency towards protection by NSAID use among those with
genetically low COX-2 activity was found. Long-term intake of
IL-10, IL-1β, COX-2, Diet and Colorectal Cancer
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aspirin (a COX-1 inhibitor) has been found to confer protection
against CRC including the presently used Diet, Cancer and
Health cohort [47]. It was not possible to assess the effects of
specific COX-2 inhibitors due to late introduction to the Danish
market and low frequency of use in the follow-up period
[47,48].
The biological interpretation of our results is supported by
other findings. IL-1B, IL-10, and COX-2 are part of the same
inflammatory pathways. IL-1 has been found to induce the
synthesis of COX-2 through activation of the pro-inflammatory
p65 unit of nuclear factor κB (NF-κB) [49]. Furthermore, IL-10
has been found to block IL-1-induced NF-κB activation in
intestinal cells (by inhibiting IκB phosphorylation) and to reduce
COX-2 induction in intestinal cells [49], The latter is in
accordance with the finding that cox-2 expression is high in
il-10 deficient mice [7]. Therefore, diet such as fibre may modify
IL10 which act as an inflammatory “gate-keeper” and thereby
affect inflammation.
Furthermore, our results suggest that those with genetically
determined low COX-2 activity are at high risk of CRC by
smoking and meat intake and, furthermore, protected by fibre
intake. Thus PTGS2 polymorphisms may have differential
impact on CRC risk dependent on environmental factors.
However, once carcinogenesis has been initiated, a high
COX-2 enzyme activity seems to be a risk factor for further
progression [7,50,51].
Taken together, our interaction analyses suggest that diet
modify intestinal carcinogenesis through impact on
inflammatory response and furthermore suggest that the effect
may differ among various populations depending on gene-
environment interactions. Our findings should be explored in
other well-characterized prospective cohorts.
This study used a nested prospective case-cohort design
and has the major advantage that data and samples were
collected before diagnosis thus minimizing the risk of
differential misclassification between cases and comparison
group. The risk estimates were adjusted for known confounding
factors affecting risk of CRC in this cohort including dietary
factors, body mass index (BMI), alcohol, smoking status and
NSAID use. A main strength of the study is the large sample
size. The genes were carefully selected based on their role in
the inflammatory pathway and the polymorphisms were mainly
selected based on their functional effects in order to allow
interpretation of the involved biological pathways in colorectal
carcinogenesis. Only the interactions between fibre and IL10,
fibre and PTGS2, vegetables and IL10, and fruit and PTGS2
withstood correction for multiple analyses. However, as our
hypothesis was biologically based we did not correct for
multiple analyses [52]. In the light of the number of statistical
tests performed, we would expect that some of the findings
may be due to chance, but the number of statistically significant
findings exceed the number expected by chance.
Conclusions
We found evidence that genetically determined variation in
IL-1β and COX-2 levels is associated with risk of CRC.
Moreover, gene-environment interactions suggest that COX-2
and IL10 are implicated in both meat-related carcinogenesis
and in the protective effects of fibre in relation to CRC. This
study demonstrates that gene-environment interactions provide
an efficient tool for identifying factors involved in colorectal
carcinogenesis. Our findings should be replicated in other well-
characterized prospective cohorts.
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